Graham D. Reeve Sells 1,730 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) Stock

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) COO Graham D. Reeve sold 1,730 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the transaction, the chief operating officer now owns 7,168 shares in the company, valued at $588,564.48. This represents a 19.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

U.S. Physical Therapy Stock Down 2.9 %

USPH stock traded down $2.37 during midday trading on Friday, hitting $80.61. The stock had a trading volume of 155,339 shares, compared to its average volume of 105,621. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The firm has a market cap of $1.22 billion, a price-to-earnings ratio of 85.76, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51. The business has a 50-day moving average of $87.21 and a two-hundred day moving average of $87.53. U.S. Physical Therapy, Inc. has a 52-week low of $76.18 and a 52-week high of $113.63.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). The firm had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. As a group, equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

Remove Ads

U.S. Physical Therapy Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be issued a $0.45 dividend. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.44. This represents a $1.80 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy's payout ratio is presently 97.83%.

Institutional Trading of U.S. Physical Therapy

Several institutional investors have recently added to or reduced their stakes in the business. HighTower Advisors LLC raised its stake in shares of U.S. Physical Therapy by 2.5% in the fourth quarter. HighTower Advisors LLC now owns 4,833 shares of the company's stock worth $429,000 after purchasing an additional 119 shares during the last quarter. CBIZ Investment Advisory Services LLC raised its position in U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after buying an additional 122 shares during the last quarter. Albert D Mason Inc. lifted its stake in U.S. Physical Therapy by 1.3% during the 4th quarter. Albert D Mason Inc. now owns 10,596 shares of the company's stock valued at $940,000 after acquiring an additional 139 shares during the period. Harbor Capital Advisors Inc. boosted its holdings in shares of U.S. Physical Therapy by 1.0% during the 4th quarter. Harbor Capital Advisors Inc. now owns 16,344 shares of the company's stock valued at $1,450,000 after acquiring an additional 156 shares during the last quarter. Finally, Aquatic Capital Management LLC grew its stake in shares of U.S. Physical Therapy by 18.0% in the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock worth $115,000 after acquiring an additional 198 shares during the period.

Analyst Upgrades and Downgrades

USPH has been the subject of a number of analyst reports. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Bank of America upgraded U.S. Physical Therapy from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $100.00 to $115.00 in a report on Monday, December 16th. StockNews.com lowered U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research report on Friday, February 28th. Citizens Jmp upgraded U.S. Physical Therapy to a "strong-buy" rating in a report on Monday, December 16th. Finally, JPMorgan Chase & Co. lifted their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an "overweight" rating in a report on Tuesday, December 3rd. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $111.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.